TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change from Baseline Bullying and Cyberbullying Scale for Adolescents (BCS-A) at 6 weeks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Feasibility Assessment - Overall
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility Assessment: Sensor Application
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility Assessment: Sensor Removal
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Infertility Affected Scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Infertility Stigma Scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SAQ-7
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Psychomotor outcomes at 2 years of corrected age
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: post-spinal hypotension
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of T cell fat-supported oxidative mitochondrial respiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of participants who completed surveys
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Proportion of participants who consider usability of online surveys as being excellent (>85) with a System Usability Scale (SUS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Colorectal cancer screening specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Colorectal cancer screening sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Reduction in Anxiety State
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes of total scores of Emotional Dysregulation Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes of total scores of Aberrant Behavior Checklist
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: Changes of total scores of Child Behavior Checklist
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: Anxiety visual analog scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital Anxiety and Depression Survey (HADS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sensitivity and specificity of 68Ga FAPI PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of successful placements of Goldballoon Detachable Balloon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of successful removals of balloon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Face-name associative memory performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mini-Mental State Evaluation (MMSE) Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mid-upper arm circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length in children <2 years of age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Löe and Silness Gingival Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of arterial blood saturation measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) and/or Recommended Dose (RED)
Endpoint domain: Physiological/clinical
Primary endpoint: Changes in HbA1c level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in fasting plasma glucose (FPG) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Catheters removed due to complications
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in the sum of longest diameters of target nodules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Numerical Rating Scale (NRS) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact of released miRNA/myokines on skeletal muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Impact of formal exercise training on skeletal muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Impact of formal exercise training on pulmonary vasculature system
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Marginal Reflex Distance (MRD1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported gastrointestinal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Patient-reported genitourinary symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Chemotherapy-Induced Taste Alteration Scale (C-TAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Simplified Nutritional Appetite Questionnaire (SNAQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Malnutrition Universal Screening Tool (MUST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-30-Version 3.0)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Tongue movement analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive and negative symptom scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with changes in left ventricular ejection fraction (LVEF) from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lead-Related Complication Free Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Sensed R-wave amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left Ventricle Global Longitudinal Strain (LVGLS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Wound infections post Caesarian section
Endpoint domain: Adverse events/effects
Primary endpoint: Number of asthma exacerbations (asthma attacks)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life - mini paediatric asthma quality of life questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Accuracy of optical diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postpartum perineal pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Richards-Campbell Sleep Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Rate of adjunctive bone and soft tissue augmentation procedures need
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Recruitment as measured by number of participants who enroll
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Attendance as measured by number of participants present at each session
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent of participants satisfied with the program as measured by self-report evaluation survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Early physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Global response assessment (GRA)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Non Arthritic Hip Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in levels of salivary minerals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of partial relief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of complete relief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Resolution of small bowel obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cmax, morning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cmax, evening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Upper Limb Kinematics - Range of Motion Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper Limb Kinematics - Angular velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of the composite endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thyroid dysfunction during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Abnormal metabolism of offspring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diabetes mellitus complicating pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Sustained smoking cessation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: venous dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from clinical or radiological osteomyelitis
Endpoint domain: Adverse events/effects
Primary endpoint: Change in patient's pain using the visual analog scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in L*, a*, b* value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: change in skin impurities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of MTD (Tolerability)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Subjective severity of MdDS-related Symptoms Self-score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in symptoms of Eating Disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Body Acceptance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in symptoms of internalization of body figure ideals
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mobilization success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and Tolerability by multiplex cytokine profiling
Endpoint domain: Adverse events/effects
Primary endpoint: Safety and Tolerability by qPCR
Endpoint domain: Adverse events/effects
Primary endpoint: Safety and Tolerability by Western blot analysis
Endpoint domain: Adverse events/effects
Primary endpoint: Safety and Tolerability by colony formation assays
Endpoint domain: Adverse events/effects
Primary endpoint: Procedural anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: DR screening completion and result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of virus copy number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Homeostatic Sleep Drive
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circadian Photosensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal Responsivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: antibody synthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Maximum Observed Concentration (Cmax) of Litifilimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-Time Curve From Time 0 to Infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of biopsies obtained for pathological diagnosis
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Arm exercise capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower extremity functional status
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Fascia thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ≥ 50% sustained decline in eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: kidney failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Usability of remote at-home speech collection - objective
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of remote at-home speech collection
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change over time in Ideal Body Beliefs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change over time in Diabetes-Specific Eating Pathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic efficacy of 68Ga-Her2-affibody PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of interbody bony fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants With One or More Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Event(s) (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Education Skills Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of participants with documented influenza vaccine receipt
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Usual infant sleep position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usual infant sleep location
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Soft bedding use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Well-Being Index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Participants with Laboratory Abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants with Dose-Limiting Toxicities (DLTs) During Dose Escalation
Endpoint domain: Adverse events/effects
Primary endpoint: Monocular uncorrected distance visual acuity (UCDVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monocular uncorrected intermediate visual acuity (UCIVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monocular uncorrected near visual acuity (UCNVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety associated with RP-A601
Endpoint domain: Adverse events/effects
Primary endpoint: Staph aureus burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Maximum concentration (Cmax) of paclitaxel plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration versus time curve from time 0 to infinity (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration versus time curve from time 0 to t (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: podobarographic parameters (plantar pressures)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Borg's dyspnea scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in proportion of informed relatives
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Informing Relatives Inventory
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diary reported number of urinary leakages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Clinical performance in restoring class II cavities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pelvic floor distress inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Covid-19 cases
Endpoint domain: Mortality/survival
Primary endpoint: Rate of Problem Behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Vertebral compression fracture (VCF) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Patients Reaching a Value of Schirmer I Test >10mm/5min at Week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Symptoms Questionnaire (SANDE) Global Score at Week 12
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of management based on multi-omic results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of pregnant females with high blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of pregnant females with severe nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of newborns with low birth weight (<2500 grams)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of euploid embryos
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First-occurrence of RT-PCR-confirmed influenza
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Oral Opioid Use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time from nodule identification to diagnosis and treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with metastatic lesions accurately detected in mCRPC using 89Zr-DFO-YS5 PET (sensitivity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IIEF Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of unscheduled consultations/hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Lactate dehydrogenase (LDH) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent change in mental health scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline Unified Parkinson's Disease Rating Scale Part III at 4 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline Unified Parkinson's Disease Rating Scale Part III at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: SDM-Q9 scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prognosis of Acute Myeloid Leukemia
Endpoint domain: Mortality/survival
Primary endpoint: Percentual reduction of LDL-c levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Thermodynamic efficiency of microwave ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Oral feeding volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants in Corticosteroid-free Clinical Remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular death or Heart Failure burden
Endpoint domain: Mortality/survival
Primary endpoint: Metformin area under the concentration vs. time curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metformin maximum concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metformin renal clearance (CLr)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Furosemide area under the concentration vs. time curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Furosemide maximum concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Furosemide renal clearance (CLr)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: The Self-Administered Patient Satisfaction Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Specificity of rhythm classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of rhythm classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reaction Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of CUSP06
Endpoint domain: Adverse events/effects